Patents Assigned to HOBIT GENOMIX, INC.
  • Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression
    Patent number: 11827719
    Abstract: The disclosure provides a pharmaceutical composition containing an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies and methods of use thereof.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: November 28, 2023
    Assignees: HOBIT GENOMIX, INC., NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
    Inventors: Hirohisa Saito, Kenji Matsumoto, Hideaki Morita, Go Ichien, Yasuhiko Koezuka, Kimishige Ishizaka